Incidence of CMV disease One year post enrollment [clinicaltrials_resource:309f141ff8b257b76f249d9b937ce42b]
CMV disease occurring after completion of prophylaxis or monitored CMV viremia testing
clinicaltrials_vocabulary:other outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:other-outcome]
Incidence of CMV disease One year post enrollment [clinicaltrials_resource:309f141ff8b257b76f249d9b937ce42b]
CMV disease occurring after completion of prophylaxis or monitored CMV viremia testing
Bio2RDF identifier
309f141ff8b257b76f249d9b937ce42b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:309f141ff8b257b76f249d9b937ce42b
measure [clinicaltrials_vocabulary:measure]
Incidence of CMV disease
time frame [clinicaltrials_vocabulary:time-frame]
One year post enrollment
description
CMV disease occurring after completion of prophylaxis or monitored CMV viremia testing
identifier
clinicaltrials_resource:309f141ff8b257b76f249d9b937ce42b
title
Incidence of CMV disease One year post enrollment
@en
type
label
Incidence of CMV disease One y ...... f141ff8b257b76f249d9b937ce42b]
@en